Addus HomeCare Corporation (ADUS)
USD 105.0
(1.04%)
USD 105.0
(1.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 110.39 Million USD | 12.54% |
| 2022 | 98.09 Million USD | 15.57% |
| 2021 | 84.87 Million USD | -0.51% |
| 2020 | 85.31 Million USD | 381.67% |
| 2019 | -30.28 Million USD | 42.99% |
| 2018 | -53.12 Million USD | -392.1% |
| 2017 | -10.79 Million USD | -163.5% |
| 2016 | 17 Million USD | 1627.4% |
| 2015 | -1.11 Million USD | 88.53% |
| 2014 | -9.7 Million USD | 37.68% |
| 2013 | -15.56 Million USD | -205.73% |
| 2012 | 14.72 Million USD | -50.11% |
| 2011 | 29.5 Million USD | -33.5% |
| 2010 | 44.36 Million USD | -8.93% |
| 2009 | 48.72 Million USD | -14.62% |
| 2008 | 57.06 Million USD | 4.45% |
| 2007 | 54.63 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 72.97 Million USD | -33.89% |
| 2024 Q2 | -123.72 Million USD | -269.53% |
| 2024 Q3 | -173.08 Million USD | -39.9% |
| 2023 Q2 | 49.06 Million USD | -44.9% |
| 2023 Q3 | 137.23 Million USD | 179.71% |
| 2023 Q4 | 110.39 Million USD | -19.56% |
| 2023 FY | 110.39 Million USD | 12.54% |
| 2023 Q1 | 89.03 Million USD | -9.23% |
| 2022 Q3 | 105.94 Million USD | -14.88% |
| 2022 Q2 | 124.47 Million USD | -31.3% |
| 2022 FY | 98.09 Million USD | 15.57% |
| 2022 Q1 | 181.17 Million USD | 113.46% |
| 2022 Q4 | 98.09 Million USD | -7.42% |
| 2021 Q4 | 84.87 Million USD | -16.66% |
| 2021 Q3 | 101.83 Million USD | 13.62% |
| 2021 Q2 | 89.62 Million USD | -14.55% |
| 2021 Q1 | 104.88 Million USD | 22.95% |
| 2021 FY | 84.87 Million USD | -0.51% |
| 2020 Q4 | 85.31 Million USD | 214.21% |
| 2020 FY | 85.31 Million USD | 381.67% |
| 2020 Q1 | -49.33 Million USD | -62.88% |
| 2020 Q3 | -74.69 Million USD | 13.02% |
| 2020 Q2 | -85.88 Million USD | -74.09% |
| 2019 Q3 | -166.83 Million USD | -3467.07% |
| 2019 Q2 | -4.67 Million USD | 87.4% |
| 2019 FY | -30.28 Million USD | 42.99% |
| 2019 Q1 | -37.11 Million USD | 30.13% |
| 2019 Q4 | -30.28 Million USD | 81.85% |
| 2018 Q4 | -53.12 Million USD | -14.81% |
| 2018 Q2 | 32.63 Million USD | 253.58% |
| 2018 Q1 | -21.24 Million USD | -96.84% |
| 2018 Q3 | -46.26 Million USD | -241.77% |
| 2018 FY | -53.12 Million USD | -392.1% |
| 2017 Q3 | -1.9 Million USD | -106.78% |
| 2017 FY | -10.79 Million USD | -163.5% |
| 2017 Q4 | -10.79 Million USD | -465.48% |
| 2017 Q2 | 28.16 Million USD | 434.24% |
| 2017 Q1 | 5.27 Million USD | -68.99% |
| 2016 FY | 17 Million USD | 1627.4% |
| 2016 Q4 | 17 Million USD | 217.41% |
| 2016 Q2 | 34.22 Million USD | 41.38% |
| 2016 Q1 | 24.2 Million USD | 2274.93% |
| 2016 Q3 | -14.47 Million USD | -142.31% |
| 2015 Q4 | -1.11 Million USD | 90.42% |
| 2015 FY | -1.11 Million USD | 88.53% |
| 2015 Q1 | -3.97 Million USD | 58.99% |
| 2015 Q3 | -11.61 Million USD | 69.83% |
| 2015 Q2 | -38.49 Million USD | -867.65% |
| 2014 Q1 | -16.96 Million USD | -8.99% |
| 2014 Q4 | -9.7 Million USD | 5.09% |
| 2014 Q2 | -19.54 Million USD | -15.18% |
| 2014 FY | -9.7 Million USD | 37.68% |
| 2014 Q3 | -10.22 Million USD | 47.7% |
| 2013 Q4 | -15.56 Million USD | 47.17% |
| 2013 Q3 | -29.46 Million USD | 24.02% |
| 2013 Q1 | -17.78 Million USD | -220.81% |
| 2013 Q2 | -38.77 Million USD | -118.04% |
| 2013 FY | -15.56 Million USD | -205.73% |
| 2012 FY | 14.72 Million USD | -50.11% |
| 2012 Q4 | 14.72 Million USD | -28.85% |
| 2012 Q3 | 20.68 Million USD | -13.92% |
| 2012 Q2 | 24.03 Million USD | -21.41% |
| 2012 Q1 | 30.58 Million USD | 3.65% |
| 2011 Q2 | 15.92 Million USD | -51.72% |
| 2011 Q3 | 33.35 Million USD | 109.49% |
| 2011 FY | 29.5 Million USD | -33.5% |
| 2011 Q4 | 29.5 Million USD | -11.54% |
| 2011 Q1 | 32.97 Million USD | -25.67% |
| 2010 Q1 | 47.36 Million USD | -2.78% |
| 2010 Q2 | 48.62 Million USD | 2.65% |
| 2010 FY | 44.36 Million USD | -8.93% |
| 2010 Q4 | 44.36 Million USD | -11.1% |
| 2010 Q3 | 49.9 Million USD | 2.65% |
| 2009 Q3 | 57.38 Million USD | -9.72% |
| 2009 FY | 48.72 Million USD | -14.62% |
| 2009 Q2 | 63.56 Million USD | 0.0% |
| 2009 Q4 | 48.72 Million USD | -15.1% |
| 2008 FY | 57.06 Million USD | 4.45% |
| 2008 Q4 | 57.06 Million USD | 0.0% |
| 2007 FY | 54.63 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 92.174% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -23.472% |
| Amedisys, Inc. | 341.35 Million USD | 67.66% |
| Astrana Health, Inc. | 27.2 Million USD | -305.745% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 92.414% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 49935.448% |
| biote Corp. | 25.86 Million USD | -326.731% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -952.349% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 1033.381% |
| COMPASS Pathways plc | -187.58 Million USD | 158.848% |
| DocGo Inc. | -12.78 Million USD | 963.171% |
| The Ensign Group, Inc. | 1.36 Billion USD | 91.893% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 1132.174% |
| InnovAge Holding Corp. | 56.08 Million USD | -96.814% |
| The Joint Corp. | -2.47 Million USD | 4552.219% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 74.459% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 1924.475% |
| ModivCare Inc. | 1.13 Billion USD | 90.293% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -39544.962% |
| Option Care Health, Inc. | 822.56 Million USD | 86.58% |
| P3 Health Partners Inc. | 83.7 Million USD | -31.878% |
| P3 Health Partners Inc. | 83.7 Million USD | -31.878% |
| The Pennant Group, Inc. | 323.57 Million USD | 65.884% |
| Surgery Partners, Inc. | 2.86 Billion USD | 96.148% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 3740.898% |
| Talkspace, Inc. | -123.9 Million USD | 189.091% |
| Talkspace, Inc. | -123.9 Million USD | 189.091% |
| The Oncology Institute, Inc. | 86.32 Million USD | -27.875% |
| The Oncology Institute, Inc. | 86.32 Million USD | -27.875% |